(1->4)-beta-D-glucan multiple interactions ISO RGD:1322981 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDKN1C mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression ISO RGD:1322981 6480464 vinylidene chloride results in decreased expression of CDKN1C mRNA CTD PMID:26682919 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1322980 6480464 Dinitrochlorobenzene results in increased expression of CDKN1C mRNA CTD PMID:20146380 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:1322981 6480464 Dinitrochlorobenzene results in decreased expression of CDKN1C mRNA CTD PMID:21404309 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CDKN1C mRNA CTD PMID:17557909 17beta-estradiol decreases expression ISO RGD:1322980 6480464 Estradiol results in decreased expression of CDKN1C mRNA CTD PMID:22064387 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CDKN1C mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO RGD:1322980 6480464 Estradiol results in increased expression of CDKN1C mRNA CTD PMID:23094148 17beta-estradiol affects expression ISO RGD:1322981 6480464 Estradiol affects the expression of CDKN1C mRNA CTD PMID:15598610 17beta-estradiol multiple interactions ISO RGD:1322980 6480464 [Estradiol co-treated with Norethindrone Acetate] results in decreased expression of CDKN1C mRNA more ... CTD PMID:22064387 more ... 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:1322980 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1322980 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDKN1C mRNA CTD PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1322981 6480464 Tetrachlorodibenzodioxin affects the expression of CDKN1C mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1322981 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDKN1C mRNA CTD PMID:19465110 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CDKN1C mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CDKN1C mRNA CTD PMID:22298810 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CDKN1C mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1322980 6480464 Lactic Acid results in decreased expression of CDKN1C mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1322980 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1C mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CDKN1C mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1322981 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of CDKN1C mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol affects methylation ISO RGD:1322981 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of CDKN1C gene CTD PMID:31683443 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:1322981 6480464 Oxazolone results in decreased expression of CDKN1C mRNA CTD PMID:21404309 4-hydroxynon-2-enal decreases expression ISO RGD:1322980 6480464 4-hydroxy-2-nonenal results in decreased expression of CDKN1C mRNA CTD PMID:12419474 4-nonylphenol increases expression ISO RGD:1322980 6480464 4-nonylphenol results in increased expression of CDKN1C protein CTD PMID:26027920 5-aza-2'-deoxycytidine increases expression ISO RGD:1322980 6480464 Decitabine results in increased expression of CDKN1C mRNA CTD PMID:19194470 5-aza-2'-deoxycytidine affects expression ISO RGD:1322980 6480464 Decitabine affects the expression of CDKN1C mRNA CTD PMID:17145863 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1322980 6480464 [Decitabine affects the methylation of CDKN1C promoter] which affects the expression of CDKN1C mRNA, [Vorinostat co-treated with Decitabine] results in increased expression of CDKN1C mRNA CTD PMID:17417771 , PMID:18454857 5-azacytidine increases expression ISO RGD:1322980 6480464 Azacitidine results in increased expression of CDKN1C mRNA CTD PMID:19194470 5-fluorouracil affects response to substance ISO RGD:1322980 6480464 CDKN1C affects the susceptibility to Fluorouracil CTD PMID:15067352 5-fluorouracil increases expression ISO RGD:1322981 6480464 Fluorouracil results in increased expression of CDKN1C mRNA CTD PMID:19272435 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of CDKN1C mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CDKN1C mRNA CTD PMID:25825206 9-cis-retinoic acid decreases expression ISO RGD:1322980 6480464 Alitretinoin results in decreased expression of CDKN1C mRNA CTD PMID:15982314 acetamide increases expression EXP 6480464 acetamide results in increased expression of CDKN1C mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CDKN1C mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1322981 6480464 Acrylamide results in decreased expression of CDKN1C mRNA CTD PMID:21319176 , PMID:35032568 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CDKN1C mRNA CTD PMID:23630614 more ... all-trans-4-oxoretinoic acid increases expression ISO RGD:1322980 6480464 4-oxoretinoic acid results in increased expression of CDKN1C mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO RGD:1322980 6480464 Tretinoin metabolite results in decreased expression of CDKN1C mRNA, Tretinoin results in decreased expression of CDKN1C mRNA CTD PMID:15982314 , PMID:23724009 ammonium chloride decreases expression EXP 6480464 Ammonium Chloride results in decreased expression of CDKN1C protein CTD PMID:16483693 amphibole asbestos decreases expression ISO RGD:1322980 6480464 Asbestos, Amphibole results in decreased expression of CDKN1C mRNA CTD PMID:20831825 anthracen-2-amine increases expression EXP 6480464 2-anthramine results in increased expression of CDKN1C mRNA CTD PMID:23038007 antirheumatic drug increases expression ISO RGD:1322980 6480464 Antirheumatic Agents results in increased expression of CDKN1C mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:1322980 6480464 Arsenic affects the methylation of CDKN1C gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1322980 6480464 Arsenic affects the methylation of CDKN1C gene CTD PMID:25304211 arsenite(3-) decreases expression ISO RGD:1322981 6480464 arsenite results in decreased expression of CDKN1C mRNA CTD PMID:18191166 atrazine multiple interactions ISO RGD:1322980 6480464 [Atrazine co-treated with Arsenates] results in increased expression of CDKN1C mRNA CTD PMID:18585445 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of CDKN1C mRNA CTD PMID:26331294 atrazine increases expression ISO RGD:1322980 6480464 Atrazine results in increased expression of CDKN1C mRNA CTD PMID:22378314 benzene increases expression ISO RGD:1322981 6480464 Benzene results in increased expression of CDKN1C mRNA CTD PMID:15050406 benzo[a]pyrene increases expression ISO RGD:1322980 6480464 Benzo(a)pyrene results in increased expression of CDKN1C mRNA CTD PMID:20064835 benzo[a]pyrene decreases expression ISO RGD:1322980 6480464 Benzo(a)pyrene results in decreased expression of CDKN1C mRNA CTD PMID:35870112 benzo[a]pyrene affects methylation ISO RGD:1322980 6480464 Benzo(a)pyrene affects the methylation of CDKN1C 3' UTR, Benzo(a)pyrene affects the methylation of CDKN1C promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CDKN1C mRNA CTD PMID:21839799 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1322980 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1322980 6480464 7 more ... CTD PMID:20018196 benzo[b]fluoranthene decreases expression ISO RGD:1322981 6480464 benzo(b)fluoranthene results in decreased expression of CDKN1C mRNA CTD PMID:26377693 berberine increases expression ISO RGD:1322980 6480464 Berberine results in increased expression of CDKN1C mRNA CTD PMID:26478571 beta-naphthoflavone decreases expression ISO RGD:1322980 6480464 beta-Naphthoflavone results in decreased expression of CDKN1C mRNA CTD PMID:32858204 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1322980 6480464 Diethylhexyl Phthalate results in increased expression of CDKN1C mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CDKN1C mRNA CTD PMID:18180321 bisphenol A increases expression ISO RGD:1322981 6480464 bisphenol A results in increased expression of CDKN1C mRNA CTD PMID:32156529 bisphenol A increases methylation ISO RGD:1322980 6480464 bisphenol A results in increased methylation of CDKN1C gene CTD PMID:28582417 bisphenol A multiple interactions ISO RGD:1322980 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1C mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CDKN1C mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1322981 6480464 bisphenol A results in decreased expression of CDKN1C mRNA CTD PMID:23593014 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CDKN1C mRNA CTD PMID:24988533 more ... bisphenol A increases expression ISO RGD:1322980 6480464 bisphenol A results in increased expression of CDKN1C protein CTD PMID:26027920 buta-1,3-diene increases expression ISO RGD:1322981 6480464 1, 3-butadiene results in increased expression of CDKN1C mRNA CTD PMID:29038090 butanal increases expression ISO RGD:1322980 6480464 butyraldehyde results in increased expression of CDKN1C mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:1322981 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDKN1C mRNA CTD PMID:36200916 cadmium dichloride increases expression ISO RGD:1322981 6480464 Cadmium Chloride results in increased expression of CDKN1C mRNA, Cadmium Chloride results in increased expression of CDKN1C protein CTD PMID:28823913 cadmium dichloride multiple interactions ISO RGD:1322981 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDKN1C mRNA CTD PMID:36200916 cadmium dichloride decreases methylation ISO RGD:1322981 6480464 Cadmium Chloride results in decreased methylation of CDKN1C promoter CTD PMID:28823913 calycosin decreases expression ISO RGD:1322980 6480464 7, 3'-dihydroxy-4'-methoxyisoflavone results in decreased expression of CDKN1C mRNA CTD PMID:24455688 carbon nanotube increases expression ISO RGD:1322980 6480464 Nanotubes, Carbon results in increased expression of CDKN1C mRNA CTD PMID:15585362 carbon nanotube increases expression ISO RGD:1322981 6480464 Nanotubes, Carbon analog results in increased expression of CDKN1C mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:1322981 6480464 Nanotubes more ... CTD PMID:25554681 carmustine affects response to substance ISO RGD:1322980 6480464 CDKN1C mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chloroprene increases expression ISO RGD:1322981 6480464 Chloroprene results in increased expression of CDKN1C mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:1322981 6480464 Chlorpyrifos results in decreased expression of CDKN1C mRNA CTD PMID:37019170 choline multiple interactions ISO RGD:1322981 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDKN1C mRNA CTD PMID:20938992 cisplatin decreases expression ISO RGD:1322980 6480464 Cisplatin results in decreased expression of CDKN1C mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:1322980 6480464 [Disulfiram binds to Copper] which results in decreased expression of CDKN1C mRNA more ... CTD PMID:20931265 more ... copper(0) multiple interactions ISO RGD:1322980 6480464 [Disulfiram binds to Copper] which results in decreased expression of CDKN1C mRNA more ... CTD PMID:20931265 more ... copper(II) sulfate affects expression ISO RGD:1322980 6480464 Copper Sulfate affects the expression of CDKN1C mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1322980 6480464 Coumestrol results in decreased expression of CDKN1C mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1322980 6480464 Asbestos, Crocidolite results in increased expression of CDKN1C mRNA CTD PMID:25351596 crocidolite asbestos decreases expression ISO RGD:1322981 6480464 Asbestos, Crocidolite results in decreased expression of CDKN1C mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CDKN1C mRNA CTD PMID:26577399 cyclophosphamide increases expression ISO RGD:1322981 6480464 Cyclophosphamide results in increased expression of CDKN1C mRNA CTD PMID:21041162 cyclosporin A decreases expression ISO RGD:1322980 6480464 Cyclosporine results in decreased expression of CDKN1C mRNA CTD PMID:27989131 cypermethrin increases expression ISO RGD:1322981 6480464 cypermethrin results in increased expression of CDKN1C mRNA, cypermethrin results in increased expression of CDKN1C protein CTD PMID:37011868 cytarabine decreases expression ISO RGD:1322980 6480464 Cytarabine results in decreased expression of CDKN1C mRNA CTD PMID:21198554 dexamethasone increases expression ISO RGD:1322981 6480464 Dexamethasone results in increased expression of CDKN1C mRNA CTD PMID:21041162 dexamethasone multiple interactions ISO RGD:1322980 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1C mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CDKN1C mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:1322980 6480464 Dexamethasone results in increased expression of CDKN1C mRNA CTD PMID:22064387 dextran sulfate multiple interactions ISO RGD:1322981 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CDKN1C mRNA CTD PMID:29950665 diazinon affects expression EXP 6480464 Diazinon affects the expression of CDKN1C mRNA CTD PMID:22546817 diazinon increases methylation ISO RGD:1322980 6480464 Diazinon results in increased methylation of CDKN1C gene CTD PMID:22964155 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CDKN1C mRNA CTD PMID:17379624 , PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CDKN1C mRNA CTD PMID:21745491 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of CDKN1C mRNA CTD PMID:22546817 diethylstilbestrol increases expression ISO RGD:1322980 6480464 Diethylstilbestrol results in increased expression of CDKN1C mRNA CTD PMID:15766595 diethylstilbestrol increases expression ISO RGD:1322981 6480464 Diethylstilbestrol results in increased expression of CDKN1C mRNA CTD PMID:21041162 dinophysistoxin 1 increases expression ISO RGD:1322980 6480464 dinophysistoxin 1 results in increased expression of CDKN1C mRNA CTD PMID:21853993 , PMID:28939011 dioxygen increases expression ISO RGD:1322980 6480464 Oxygen deficiency results in increased expression of CDKN1C mRNA CTD PMID:17914565 more ... disodium selenite increases expression ISO RGD:1322980 6480464 Sodium Selenite results in increased expression of CDKN1C mRNA CTD PMID:16705456 disulfiram multiple interactions ISO RGD:1322980 6480464 [Disulfiram binds to Copper] which results in decreased expression of CDKN1C mRNA CTD PMID:24690739 diuron increases expression EXP 6480464 Diuron results in increased expression of CDKN1C mRNA CTD PMID:21551480 divanadium pentaoxide decreases expression ISO RGD:1322980 6480464 vanadium pentoxide results in decreased expression of CDKN1C mRNA CTD PMID:17459161 dorsomorphin multiple interactions ISO RGD:1322980 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN1C mRNA CTD PMID:27188386 doxorubicin affects expression ISO RGD:1322980 6480464 Doxorubicin affects the expression of CDKN1C mRNA CTD PMID:29803840 elemental selenium decreases expression ISO RGD:1322980 6480464 Selenium results in decreased expression of CDKN1C mRNA CTD PMID:19244175 emodin increases expression ISO RGD:1322981 6480464 Emodin results in increased expression of CDKN1C mRNA CTD PMID:21319176 ethanol increases expression ISO RGD:1322981 6480464 Ethanol results in increased expression of CDKN1C mRNA CTD PMID:19167417 fenamidone increases expression ISO RGD:1322981 6480464 fenamidone results in increased expression of CDKN1C mRNA CTD PMID:27029645 folic acid multiple interactions ISO RGD:1322981 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDKN1C mRNA CTD PMID:20938992 formaldehyde increases expression ISO RGD:1322980 6480464 Formaldehyde results in increased expression of CDKN1C mRNA CTD PMID:17938736 genistein decreases expression ISO RGD:1322980 6480464 Genistein results in decreased expression of CDKN1C mRNA CTD PMID:23019147 genistein decreases expression ISO RGD:1322981 6480464 Genistein results in decreased expression of CDKN1C mRNA CTD PMID:31593742 genistein increases expression ISO RGD:1322980 6480464 Genistein results in increased expression of CDKN1C mRNA CTD PMID:22228119 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of CDKN1C mRNA CTD PMID:24395379 harmine decreases expression ISO RGD:1322980 6480464 Harmine results in decreased expression of CDKN1C mRNA, Harmine results in decreased expression of CDKN1C protein CTD PMID:25751815 hydrogen peroxide affects expression ISO RGD:1322980 6480464 Hydrogen Peroxide affects the expression of CDKN1C mRNA, Hydrogen Peroxide affects the expression of CDKN1C protein CTD PMID:20044591 , PMID:21179406 hydroquinone decreases expression ISO RGD:1322980 6480464 hydroquinone results in decreased expression of CDKN1C mRNA CTD PMID:31256213 hydroxyurea increases expression ISO RGD:1322981 6480464 Hydroxyurea results in increased expression of CDKN1C mRNA CTD PMID:12929121 indometacin multiple interactions ISO RGD:1322980 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1C mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CDKN1C mRNA CTD PMID:28628672 iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of CDKN1C mRNA CTD PMID:16629162 iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of CDKN1C mRNA CTD PMID:16629162 isoliquiritigenin decreases expression ISO RGD:1322981 6480464 isoliquiritigenin results in decreased expression of CDKN1C mRNA CTD PMID:27702603 isotretinoin decreases expression ISO RGD:1322980 6480464 Isotretinoin results in decreased expression of CDKN1C mRNA CTD PMID:15982314 L-methionine multiple interactions ISO RGD:1322981 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDKN1C mRNA CTD PMID:20938992 lamivudine multiple interactions ISO RGD:1322980 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1C mRNA CTD PMID:15784690 Licochalcone B increases expression ISO RGD:1322980 6480464 licochalcone B results in increased expression of CDKN1C mRNA CTD PMID:33647349 linalool increases expression ISO RGD:1322980 6480464 linalool results in increased expression of CDKN1C mRNA CTD PMID:19922762 lipopolysaccharide increases expression ISO RGD:1322981 6480464 Lipopolysaccharides results in increased expression of CDKN1C mRNA CTD PMID:12057914 lipopolysaccharide decreases expression ISO RGD:1322980 6480464 Lipopolysaccharides results in decreased expression of CDKN1C mRNA CTD PMID:18192897 lithium chloride increases expression ISO RGD:1322980 6480464 Lithium Chloride results in increased expression of CDKN1C mRNA CTD PMID:17440966 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of CDKN1C mRNA CTD PMID:28801915 menadione affects expression ISO RGD:1322980 6480464 Vitamin K 3 affects the expression of CDKN1C mRNA CTD PMID:20044591 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of CDKN1C gene CTD PMID:35440735 methylmercury chloride decreases expression ISO RGD:1322980 6480464 methylmercuric chloride results in decreased expression of CDKN1C mRNA CTD PMID:23179753 methylmercury chloride increases expression ISO RGD:1322980 6480464 methylmercuric chloride results in increased expression of CDKN1C mRNA CTD PMID:28001369 methylseleninic acid increases expression ISO RGD:1322980 6480464 methylselenic acid results in increased expression of CDKN1C mRNA CTD PMID:18548127 methylseleninic acid affects expression ISO RGD:1322980 6480464 methylselenic acid affects the expression of CDKN1C mRNA CTD PMID:14617803 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1322981 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1C mRNA CTD PMID:31884101 monobenzyl phthalate multiple interactions ISO RGD:1322981 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1C mRNA CTD PMID:31884101 monoethyl phthalate multiple interactions ISO RGD:1322981 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1C mRNA CTD PMID:31884101 monosodium L-glutamate multiple interactions ISO RGD:1322981 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of CDKN1C mRNA CTD PMID:19001666 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CDKN1C mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression ISO RGD:1322981 6480464 Diethylnitrosamine results in increased expression of CDKN1C mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1322981 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDKN1C mRNA] CTD PMID:17854601 nickel atom decreases expression ISO RGD:1322980 6480464 Nickel results in decreased expression of CDKN1C mRNA CTD PMID:24768652 , PMID:25583101 nickel subsulfide decreases expression EXP 6480464 nickel subsulfide results in decreased expression of CDKN1C, nickel subsulfide results in decreased expression of CDKN1C mRNA CTD PMID:23447020 , PMID:24952340 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CDKN1C mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of CDKN1C mRNA CTD PMID:25729387 p-anisidine increases expression ISO RGD:1322981 6480464 4-anisidine results in increased expression of CDKN1C mRNA CTD PMID:12929121 paracetamol increases expression ISO RGD:1322980 6480464 Acetaminophen results in increased expression of CDKN1C mRNA CTD PMID:21420995 paracetamol affects expression ISO RGD:1322980 6480464 Acetaminophen affects the expression of CDKN1C mRNA CTD PMID:25458485 paraquat decreases expression ISO RGD:1322981 6480464 Paraquat results in decreased expression of CDKN1C mRNA CTD PMID:21371552 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CDKN1C mRNA CTD PMID:32680482 pentanal increases expression ISO RGD:1322980 6480464 pentanal results in increased expression of CDKN1C mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of CDKN1C mRNA CTD PMID:18692542 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1322981 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDKN1C mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CDKN1C mRNA CTD PMID:36331819 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1322980 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CDKN1C mRNA CTD PMID:16979875 pioglitazone multiple interactions ISO RGD:1322980 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA CTD PMID:20847119 pirinixic acid multiple interactions ISO RGD:1322980 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CDKN1C mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1322981 6480464 pirinixic acid results in increased expression of CDKN1C mRNA CTD PMID:23811191 progesterone multiple interactions ISO RGD:1322980 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CDKN1C mRNA CTD PMID:22064387 progesterone increases expression EXP 6480464 Progesterone results in increased expression of CDKN1C mRNA CTD PMID:20726854 pyrogallol decreases expression ISO RGD:1322981 6480464 Pyrogallol results in decreased expression of CDKN1C mRNA CTD PMID:20362636 pyrogallol multiple interactions ISO RGD:1322981 6480464 Silymarin inhibits the reaction [Pyrogallol results in decreased expression of CDKN1C mRNA] CTD PMID:20362636 quercetin increases expression ISO RGD:1322980 6480464 Quercetin results in increased expression of CDKN1C mRNA CTD PMID:14715546 , PMID:27514524 rac-lactic acid decreases expression ISO RGD:1322980 6480464 Lactic Acid results in decreased expression of CDKN1C mRNA CTD PMID:30851411 reactive oxygen species increases expression ISO RGD:1322980 6480464 Reactive Oxygen Species results in increased expression of CDKN1C mRNA CTD PMID:25800948 resveratrol increases expression ISO RGD:1322980 6480464 resveratrol results in increased expression of CDKN1C mRNA CTD PMID:12569576 , PMID:20878097 SB 431542 multiple interactions ISO RGD:1322980 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN1C mRNA CTD PMID:27188386 selenium atom decreases expression ISO RGD:1322980 6480464 Selenium results in decreased expression of CDKN1C mRNA CTD PMID:19244175 serpentine asbestos decreases expression ISO RGD:1322980 6480464 Asbestos, Serpentine results in decreased expression of CDKN1C mRNA CTD PMID:29523930 silicon dioxide decreases expression ISO RGD:1322980 6480464 Silicon Dioxide analog results in decreased expression of CDKN1C mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1322980 6480464 Silicon Dioxide results in increased expression of CDKN1C mRNA CTD PMID:25351596 simvastatin increases expression ISO RGD:1322980 6480464 Simvastatin results in increased expression of CDKN1C mRNA CTD PMID:17428261 sodium arsenite increases expression ISO RGD:1322981 6480464 sodium arsenite results in increased expression of CDKN1C mRNA CTD PMID:17451858 sodium dodecyl sulfate increases expression ISO RGD:1322980 6480464 Sodium Dodecyl Sulfate results in increased expression of CDKN1C mRNA CTD PMID:31734321 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of CDKN1C mRNA CTD PMID:27257137 sotorasib multiple interactions ISO RGD:1322980 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CDKN1C mRNA CTD PMID:36139627 sterigmatocystin affects expression EXP 6480464 Sterigmatocystin affects the expression of CDKN1C mRNA CTD PMID:34126181 sulforaphane decreases expression ISO RGD:1322980 6480464 sulforaphane results in decreased expression of CDKN1C mRNA CTD PMID:31838189 temozolomide affects response to substance ISO RGD:1322980 6480464 CDKN1C mRNA affects the susceptibility to temozolomide CTD PMID:16365179 tert-butyl hydroperoxide multiple interactions ISO RGD:1322980 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide increases expression ISO RGD:1322980 6480464 tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA CTD PMID:20847119 tert-butyl hydroperoxide decreases expression ISO RGD:1322980 6480464 tert-Butylhydroperoxide results in decreased expression of CDKN1C mRNA CTD PMID:12419474 testosterone decreases expression ISO RGD:1322981 6480464 Testosterone results in decreased expression of CDKN1C mRNA CTD PMID:20403060 testosterone increases expression ISO RGD:1322981 6480464 Testosterone deficiency results in increased expression of CDKN1C mRNA CTD PMID:33848595 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CDKN1C mRNA CTD PMID:31150632 theophylline increases expression ISO RGD:1322980 6480464 Theophylline results in increased expression of CDKN1C mRNA CTD PMID:16083514 thimerosal decreases expression ISO RGD:1322980 6480464 Thimerosal results in decreased expression of CDKN1C mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CDKN1C mRNA CTD PMID:22659510 titanium dioxide decreases expression ISO RGD:1322981 6480464 titanium dioxide results in decreased expression of CDKN1C mRNA CTD PMID:23409001 titanium dioxide multiple interactions ISO RGD:1322981 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CDKN1C mRNA CTD PMID:29950665 toluene 2,4-diisocyanate decreases expression ISO RGD:1322981 6480464 Toluene 2, 4-Diisocyanate results in decreased expression of CDKN1C mRNA CTD PMID:21404309 topotecan increases expression EXP 6480464 Topotecan results in increased expression of CDKN1C mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CDKN1C mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:1322980 6480464 CDKN1C protein affects the susceptibility to Topotecan CTD PMID:16217747 trametinib multiple interactions ISO RGD:1322980 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CDKN1C mRNA CTD PMID:36139627 trichostatin A increases expression ISO RGD:1322980 6480464 trichostatin A results in increased expression of CDKN1C mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1322980 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN1C mRNA CTD PMID:27188386 trichostatin A decreases expression ISO RGD:1322980 6480464 trichostatin A results in decreased expression of CDKN1C mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:1322980 6480464 Triclosan results in increased expression of CDKN1C mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1322981 6480464 trimellitic anhydride results in decreased expression of CDKN1C mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:1322981 6480464 triptonide results in increased expression of CDKN1C mRNA CTD PMID:33045310 troglitazone multiple interactions ISO RGD:1322980 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA more ... CTD PMID:20847119 tunicamycin decreases expression ISO RGD:1322981 6480464 Tunicamycin results in decreased expression of CDKN1C mRNA CTD PMID:17127020 urethane decreases expression ISO RGD:1322981 6480464 Urethane results in decreased expression of CDKN1C mRNA CTD PMID:12117781 valproic acid increases expression ISO RGD:1322980 6480464 Valproic Acid results in increased expression of CDKN1C mRNA, Valproic Acid results in increased expression of CDKN1C protein CTD PMID:22083351 , PMID:28001369 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CDKN1C mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:1322980 6480464 Valproic Acid results in decreased expression of CDKN1C mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:1322980 6480464 Valproic Acid affects the expression of CDKN1C mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:1322980 6480464 Valproic Acid results in increased methylation of CDKN1C gene CTD PMID:29154799 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CDKN1C mRNA CTD PMID:19015723 vorinostat multiple interactions ISO RGD:1322980 6480464 [vorinostat co-treated with decitabine] results in increased expression of CDKN1C mRNA, CDKN1C mutant form inhibits the reaction [[(+)-JQ1 compound co-treated with vorinostat] results in increased cleavage of PARP1 protein] CTD PMID:17417771 , PMID:26390243 vorinostat multiple interactions ISO RGD:1322981 6480464 [(+)-JQ1 compound co-treated with vorinostat] affects the expression of CDKN1C mRNA more ... CTD PMID:26390243 vorinostat increases expression ISO RGD:1322980 6480464 vorinostat results in increased expression of CDKN1C mRNA, vorinostat results in increased expression of CDKN1C protein CTD PMID:17417771 , PMID:22083351 vorinostat decreases expression ISO RGD:1322980 6480464 vorinostat results in decreased expression of CDKN1C mRNA CTD PMID:27188386 zearalenone decreases expression ISO RGD:1322980 6480464 Zearalenone results in decreased expression of CDKN1C mRNA CTD PMID:28965971 zidovudine multiple interactions ISO RGD:1322980 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1C mRNA CTD PMID:15784690 zinc atom multiple interactions ISO RGD:1322980 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CDKN1C mRNA CTD PMID:16979875 zinc atom increases expression ISO RGD:1322980 6480464 Zinc results in increased expression of CDKN1C mRNA CTD PMID:19071009 zinc(0) multiple interactions ISO RGD:1322980 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CDKN1C mRNA CTD PMID:16979875 zinc(0) increases expression ISO RGD:1322980 6480464 Zinc results in increased expression of CDKN1C mRNA CTD PMID:19071009 zoledronic acid increases expression ISO RGD:1322980 6480464 zoledronic acid results in increased expression of CDKN1C mRNA CTD PMID:20977926
